Published in Mult Scler on July 16, 2008
Quantifying federal funding and scholarly output related to the academic emergency medicine consensus conferences. Acad Med (2014) 0.84
Ready or not: planning for health declines in couples with advanced multiple sclerosis. J Neurosci Nurs (2013) 0.81
Rehabilitation challenges in multiple sclerosis. Ann Indian Acad Neurol (2009) 0.79
Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler (2008) 0.77
Perspectives on self-management in multiple sclerosis: a focus group study. Int J MS Care (2011) 0.76
Beyond depression: Predictors of self-reported cognitive function in adults living with MS. Rehabil Psychol (2015) 0.75
Pain, fatigue, and cognitive symptoms are temporally associated within- but not across-days in multiple sclerosis. Arch Phys Med Rehabil (2017) 0.75
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) (2000) 22.00
Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol (1993) 18.09
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) Am J Ind Med (1996) 16.45
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med (1991) 10.55
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976) (1998) 6.51
Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56
The academic base for general practice: the case for change. BMJ (1993) 5.25
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther (2001) 5.10
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ (2001) 4.06
Waiting times for knee-replacement surgery in the United States and Ontario. N Engl J Med (1994) 3.96
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
Health-related quality of life after knee replacement. J Bone Joint Surg Am (1998) 3.88
Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res (1996) 3.40
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
A taxonomy for responsiveness. J Clin Epidemiol (2001) 3.03
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol (1997) 2.92
What do we know about the reliability and validity of physical examination tests used to examine the upper extremity? J Hand Surg Am (1999) 2.65
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev (2002) 2.65
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun (2005) 2.47
Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet (2001) 2.47
A model for clinical governance in primary care groups. BMJ (1999) 2.44
Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol (1999) 2.38
Oral ketamine preanesthetic medication in children. Anesthesiology (1992) 2.35
Pituitary ablation for diabetic retinopathy. Q J Med (1965) 2.34
"Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum (2001) 2.24
Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol (1995) 2.23
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet (2007) 2.15
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol (1993) 2.14
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Preventing disability from work-related low-back pain. New evidence gives new hope--if we can just get all the players onside. CMAJ (1998) 2.12
Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med (1986) 2.08
Vagus nerve stimulation for symptomatic generalized epilepsy: a pilot study. Epilepsia (1998) 2.08
Disordered gastric motor function in diabetes mellitus. Diabetologia (1994) 2.07
Menses and breast cancer: does timing of mammographically directed core biopsy affect outcome? J Surg Oncol (2000) 2.07
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med (1997) 2.04
Socioeconomic factors affecting the utilization of surgical operations. N Engl J Med (1977) 2.02
The classical arabinogalactan protein gene family of arabidopsis. Plant Cell (2000) 2.00
A systematic review of the prognosis of acute whiplash and a new conceptual framework to synthesize the literature. Spine (Phila Pa 1976) (2001) 1.99
Accuracy of the Denver-II in developmental screening. Pediatrics (1992) 1.97
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis (2004) 1.92
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
The complex structures of arabinogalactan-proteins and the journey towards understanding function. Plant Mol Biol (2001) 1.84
Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab (1998) 1.80
Ontario patients' acceptance of waiting times for knee replacements. J Rheumatol (1994) 1.80
Biomechanical and psychosocial risk factors for low back pain at work. Am J Public Health (2001) 1.78
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci (Lond) (1981) 1.76
A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med (1973) 1.76
Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn (2002) 1.74
What proportion of patients refuse consent to data collection from their records for research purposes? Br J Gen Pract (2000) 1.74
Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett (1994) 1.71
Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev (2002) 1.69
Postanesthetic apnea in full-term infants after pyloromyotomy. Anesthesiology (1994) 1.67
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. J Rheumatol (1983) 1.66
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol (2001) 1.64
Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64
Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients. Clin Pharmacol Ther (1980) 1.64
Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) (2000) 1.64
Osteoarthritis of the hip and knee and mechanical occupational exposure--a systematic overview of the evidence. J Rheumatol (1997) 1.62
An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol (1967) 1.62
Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens (1992) 1.60
Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60
Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum (1999) 1.59
Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut (1999) 1.59
Attitudes toward genetic research review: results from a survey of human genetics researchers. Public Health Genomics (2011) 1.58
Normal insulin response to glucose. Lancet (1966) 1.58
Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. J Clin Epidemiol (2009) 1.57
Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1992) 1.56
Classification systems of soft tissue disorders of the neck and upper limb: do they satisfy methodological guidelines? J Clin Epidemiol (1996) 1.56
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet (1990) 1.56
Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum (1989) 1.55
A randomized controlled trial to assess the incidence of new onset hypertension in patients after shock wave lithotripsy for asymptomatic renal calculi. J Urol (1998) 1.54
Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut (1994) 1.51
Variation in orthopedic surgeons' perceptions of the indications for and outcomes of knee replacement. CMAJ (1995) 1.51
Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen (2007) 1.41
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) (2012) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
The effectiveness of a regulatory strategy in containing hospital costs. The Ontario experience, 1967-1981. N Engl J Med (1983) 1.39
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum (1999) 1.38
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol (2000) 1.37
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37
Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. J Hand Ther (2000) 1.36
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol (1994) 1.35
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34
Accuracy of administrative data for assessing outcomes after knee replacement surgery. J Clin Epidemiol (1997) 1.34
Validity of rheumatoid arthritis diagnoses listed in the Saskatchewan Hospital Separations Database. J Clin Epidemiol (1993) 1.34
Reverse genetics of nodaviruses. Adv Virus Res (1999) 1.33
Outcome measures for studying patients with low back pain. Spine (Phila Pa 1976) (1994) 1.33